Orai1	B:C4255013
-	O
Mediated	O
Antimicrobial	O
Secretion	O
from	O
Pancreatic	O
Acini	I:C0227578
Shapes	O
the	O
Gut	O
Microbiome	O
and	O
Regulates	O
Gut	O
Innate	O
Immunity	O
.	O

Orai1	O
-	O
Mediated	O
Antimicrobial	B:C1136254
Secretion	O
from	O
Pancreatic	O
Acini	I:C0227578
Shapes	O
the	O
Gut	O
Microbiome	O
and	O
Regulates	O
Gut	O
Innate	O
Immunity	O
.	O

Orai1	O
-	O
Mediated	O
Antimicrobial	O
Secretion	B:C0036537
from	O
Pancreatic	O
Acini	I:C0227578
Shapes	O
the	O
Gut	O
Microbiome	O
and	O
Regulates	O
Gut	O
Innate	O
Immunity	O
.	O

Orai1	O
-	O
Mediated	O
Antimicrobial	O
Secretion	O
from	O
Pancreatic	B:C0227578
Acini	I:C0227578
Shapes	O
the	O
Gut	O
Microbiome	O
and	O
Regulates	O
Gut	O
Innate	O
Immunity	O
.	O

Orai1	O
-	O
Mediated	O
Antimicrobial	O
Secretion	O
from	O
Pancreatic	O
Acini	I:C0227578
Shapes	O
the	O
Gut	O
Microbiome	O
and	O
Regulates	B:C1155268
Gut	O
Innate	O
Immunity	O
.	O

Orai1	O
-	O
Mediated	O
Antimicrobial	O
Secretion	O
from	O
Pancreatic	O
Acini	I:C0227578
Shapes	O
the	O
Gut	O
Microbiome	O
and	O
Regulates	O
Gut	B:C0699819
Innate	O
Immunity	O
.	O

The	O
gut	O
microbiome	O
participates	O
in	O
numerous	O
physiologic	O
functions	O
and	O
communicates	B:C0566001
intimately	O
with	O
the	O
host	O
immune	O
system	I:C0020962
.	O

The	O
gut	O
microbiome	O
participates	O
in	O
numerous	O
physiologic	O
functions	O
and	O
communicates	O
intimately	O
with	O
the	O
host	O
immune	B:C0020962
system	I:C0020962
.	O

Antimicrobial	B:C4084937
peptides	I:C4084937
are	O
critica	O
l	O
components	O
of	O
intestinal	O
innate	O
immunity	O
.	O

Antimicrobial	O
peptides	I:C4084937
are	O
critica	O
l	O
components	B:C1179435
of	O
intestinal	O
innate	O
immunity	O
.	O

Antimicrobial	O
peptides	I:C4084937
are	O
critica	O
l	O
components	O
of	O
intestinal	B:C0021853
innate	O
immunity	O
.	O

We	O
report	O
a	O
prominent	O
role	O
for	O
antimicrobials	B:C1819788
secreted	I:C1819788
by	O
pancreatic	O
acini	I:C0227578
in	O
shaping	O
the	O
gut	O
microbiome	O
that	O
is	O
essential	O
for	O
intestinal	O
innate	O
immunity	O
,	O
barrier	O
function	O
,	O
and	O
survival	O
.	O

We	O
report	O
a	O
prominent	O
role	O
for	O
antimicrobials	O
secreted	I:C1819788
by	O
pancreatic	B:C0227578
acini	I:C0227578
in	O
shaping	O
the	O
gut	O
microbiome	O
that	O
is	O
essential	O
for	O
intestinal	O
innate	O
immunity	O
,	O
barrier	O
function	O
,	O
and	O
survival	O
.	O

We	O
report	O
a	O
prominent	O
role	O
for	O
antimicrobials	O
secreted	I:C1819788
by	O
pancreatic	O
acini	I:C0227578
in	O
shaping	O
the	O
gut	O
microbiome	O
that	O
is	O
essential	O
for	O
intestinal	B:C0021853
innate	O
immunity	O
,	O
barrier	O
function	O
,	O
and	O
survival	O
.	O

Deletion	O
of	O
the	O
Ca(	B:C1823405
2+	I:C1823405
)	I:C1823405
channel	I:C1823405
Orai1	I:C1823405
in	O
pancreatic	O
acini	I:C0227578
of	O
adult	O
mice	O
resulted	O
in	O
60	O
%	O
-	O
70	O
%	O
mortality	O
within	O
3	O
weeks	O
.	O

Deletion	O
of	O
the	O
Ca(	O
2+	I:C1823405
)	I:C1823405
channel	I:C1823405
Orai1	I:C1823405
in	O
pancreatic	B:C0227578
acini	I:C0227578
of	O
adult	O
mice	O
resulted	O
in	O
60	O
%	O
-	O
70	O
%	O
mortality	O
within	O
3	O
weeks	O
.	O

Deletion	O
of	O
the	O
Ca(	O
2+	I:C1823405
)	I:C1823405
channel	I:C1823405
Orai1	I:C1823405
in	O
pancreatic	O
acini	I:C0227578
of	O
adult	O
mice	B:C0026809
resulted	O
in	O
60	O
%	O
-	O
70	O
%	O
mortality	O
within	O
3	O
weeks	O
.	O

Despite	O
robust	O
activation	B:C1817386
of	I:C1817386
the	I:C1817386
intestinal	I:C1817386
innate	I:C1817386
immune	I:C1817386
response	I:C1817386
,	O
mice	O
lacking	O
acinar	O
Orai1	O
exhibited	O
intestinal	O
bacterial	O
outgrowth	O
and	O
dysbiosis	O
,	O
ultimately	O
causing	O
systemic	O
translocation	O
,	O
inflammation	O
,	O
and	O
death	O
.	O

Despite	O
robust	O
activation	O
of	I:C1817386
the	I:C1817386
intestinal	I:C1817386
innate	I:C1817386
immune	I:C1817386
response	I:C1817386
,	O
mice	B:C0026809
lacking	O
acinar	O
Orai1	O
exhibited	O
intestinal	O
bacterial	O
outgrowth	O
and	O
dysbiosis	O
,	O
ultimately	O
causing	O
systemic	O
translocation	O
,	O
inflammation	O
,	O
and	O
death	O
.	O

Despite	O
robust	O
activation	O
of	I:C1817386
the	I:C1817386
intestinal	I:C1817386
innate	I:C1817386
immune	I:C1817386
response	I:C1817386
,	O
mice	O
lacking	O
acinar	B:C0332207
Orai1	O
exhibited	O
intestinal	O
bacterial	O
outgrowth	O
and	O
dysbiosis	O
,	O
ultimately	O
causing	O
systemic	O
translocation	O
,	O
inflammation	O
,	O
and	O
death	O
.	O

Despite	O
robust	O
activation	O
of	I:C1817386
the	I:C1817386
intestinal	I:C1817386
innate	I:C1817386
immune	I:C1817386
response	I:C1817386
,	O
mice	O
lacking	O
acinar	O
Orai1	B:C1823405
exhibited	O
intestinal	O
bacterial	O
outgrowth	O
and	O
dysbiosis	O
,	O
ultimately	O
causing	O
systemic	O
translocation	O
,	O
inflammation	O
,	O
and	O
death	O
.	O

Despite	O
robust	O
activation	O
of	I:C1817386
the	I:C1817386
intestinal	I:C1817386
innate	I:C1817386
immune	I:C1817386
response	I:C1817386
,	O
mice	O
lacking	O
acinar	O
Orai1	O
exhibited	O
intestinal	B:C0021853
bacterial	O
outgrowth	O
and	O
dysbiosis	O
,	O
ultimately	O
causing	O
systemic	O
translocation	O
,	O
inflammation	O
,	O
and	O
death	O
.	O

Despite	O
robust	O
activation	O
of	I:C1817386
the	I:C1817386
intestinal	I:C1817386
innate	I:C1817386
immune	I:C1817386
response	I:C1817386
,	O
mice	O
lacking	O
acinar	O
Orai1	O
exhibited	O
intestinal	O
bacterial	O
outgrowth	B:C0007613
and	O
dysbiosis	O
,	O
ultimately	O
causing	O
systemic	O
translocation	O
,	O
inflammation	O
,	O
and	O
death	O
.	O

Despite	O
robust	O
activation	O
of	I:C1817386
the	I:C1817386
intestinal	I:C1817386
innate	I:C1817386
immune	I:C1817386
response	I:C1817386
,	O
mice	O
lacking	O
acinar	O
Orai1	O
exhibited	O
intestinal	O
bacterial	O
outgrowth	O
and	O
dysbiosis	O
,	O
ultimately	O
causing	O
systemic	O
translocation	B:C0599718
,	O
inflammation	O
,	O
and	O
death	O
.	O

Despite	O
robust	O
activation	O
of	I:C1817386
the	I:C1817386
intestinal	I:C1817386
innate	I:C1817386
immune	I:C1817386
response	I:C1817386
,	O
mice	O
lacking	O
acinar	O
Orai1	O
exhibited	O
intestinal	O
bacterial	O
outgrowth	O
and	O
dysbiosis	O
,	O
ultimately	O
causing	O
systemic	O
translocation	O
,	O
inflammation	B:C0021368
,	O
and	O
death	O
.	O

Despite	O
robust	O
activation	O
of	I:C1817386
the	I:C1817386
intestinal	I:C1817386
innate	I:C1817386
immune	I:C1817386
response	I:C1817386
,	O
mice	O
lacking	O
acinar	O
Orai1	O
exhibited	O
intestinal	O
bacterial	O
outgrowth	O
and	O
dysbiosis	O
,	O
ultimately	O
causing	O
systemic	O
translocation	O
,	O
inflammation	O
,	O
and	O
death	B:C0011065
.	O

While	O
digestive	B:C0544420
enzyme	I:C0544420
supplementation	O
was	O
ineffective	O
,	O
treatments	O
constraining	O
bacterial	O
outgrowth	O
(	O
purified	O
liquid	O
diet	I:C0301571
,	O
broad	O
-	I:C0003232
spectrum	I:C0003232
antibiotics	I:C0003232
)	O
rescued	O
survival	O
,	O
feeding	O
,	O
and	O
weight	O
gain	I:C0043094
.	O

While	O
digestive	O
enzyme	I:C0544420
supplementation	B:C0948571
was	O
ineffective	O
,	O
treatments	O
constraining	O
bacterial	O
outgrowth	O
(	O
purified	O
liquid	O
diet	I:C0301571
,	O
broad	O
-	I:C0003232
spectrum	I:C0003232
antibiotics	I:C0003232
)	O
rescued	O
survival	O
,	O
feeding	O
,	O
and	O
weight	O
gain	I:C0043094
.	O

While	O
digestive	O
enzyme	I:C0544420
supplementation	O
was	O
ineffective	O
,	O
treatments	B:C0087111
constraining	O
bacterial	O
outgrowth	O
(	O
purified	O
liquid	O
diet	I:C0301571
,	O
broad	O
-	I:C0003232
spectrum	I:C0003232
antibiotics	I:C0003232
)	O
rescued	O
survival	O
,	O
feeding	O
,	O
and	O
weight	O
gain	I:C0043094
.	O

While	O
digestive	O
enzyme	I:C0544420
supplementation	O
was	O
ineffective	O
,	O
treatments	O
constraining	O
bacterial	O
outgrowth	B:C0007613
(	O
purified	O
liquid	O
diet	I:C0301571
,	O
broad	O
-	I:C0003232
spectrum	I:C0003232
antibiotics	I:C0003232
)	O
rescued	O
survival	O
,	O
feeding	O
,	O
and	O
weight	O
gain	I:C0043094
.	O

While	O
digestive	O
enzyme	I:C0544420
supplementation	O
was	O
ineffective	O
,	O
treatments	O
constraining	O
bacterial	O
outgrowth	O
(	O
purified	O
liquid	B:C0301571
diet	I:C0301571
,	O
broad	O
-	I:C0003232
spectrum	I:C0003232
antibiotics	I:C0003232
)	O
rescued	O
survival	O
,	O
feeding	O
,	O
and	O
weight	O
gain	I:C0043094
.	O

While	O
digestive	O
enzyme	I:C0544420
supplementation	O
was	O
ineffective	O
,	O
treatments	O
constraining	O
bacterial	O
outgrowth	O
(	O
purified	O
liquid	O
diet	I:C0301571
,	O
broad	B:C0003232
-	I:C0003232
spectrum	I:C0003232
antibiotics	I:C0003232
)	O
rescued	O
survival	O
,	O
feeding	O
,	O
and	O
weight	O
gain	I:C0043094
.	O

While	O
digestive	O
enzyme	I:C0544420
supplementation	O
was	O
ineffective	O
,	O
treatments	O
constraining	O
bacterial	O
outgrowth	O
(	O
purified	O
liquid	O
diet	I:C0301571
,	O
broad	O
-	I:C0003232
spectrum	I:C0003232
antibiotics	I:C0003232
)	O
rescued	O
survival	O
,	O
feeding	O
,	O
and	O
weight	B:C0043094
gain	I:C0043094
.	O

Pancreatic	B:C1306845
levels	I:C1306845
of	O
cathelicidin	O
-	O
related	O
antimicrobial	O
peptide	I:C4084937
(	O
cathelicidin	O
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
)	O
were	O
reduced	O
,	O
and	O
supplement	O
of	O
synthetic	O
cathelicidin	O
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
prevented	O
intestinal	O
disease	I:C0021831
.	O

Pancreatic	O
levels	I:C1306845
of	O
cathelicidin	B:C0671062
-	O
related	O
antimicrobial	O
peptide	I:C4084937
(	O
cathelicidin	O
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
)	O
were	O
reduced	O
,	O
and	O
supplement	O
of	O
synthetic	O
cathelicidin	O
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
prevented	O
intestinal	O
disease	I:C0021831
.	O

Pancreatic	O
levels	I:C1306845
of	O
cathelicidin	O
-	O
related	O
antimicrobial	B:C4084937
peptide	I:C4084937
(	O
cathelicidin	O
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
)	O
were	O
reduced	O
,	O
and	O
supplement	O
of	O
synthetic	O
cathelicidin	O
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
prevented	O
intestinal	O
disease	I:C0021831
.	O

Pancreatic	O
levels	I:C1306845
of	O
cathelicidin	O
-	O
related	O
antimicrobial	O
peptide	I:C4084937
(	O
cathelicidin	B:C4084937
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
)	O
were	O
reduced	O
,	O
and	O
supplement	O
of	O
synthetic	O
cathelicidin	O
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
prevented	O
intestinal	O
disease	I:C0021831
.	O

Pancreatic	O
levels	I:C1306845
of	O
cathelicidin	O
-	O
related	O
antimicrobial	O
peptide	I:C4084937
(	O
cathelicidin	O
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
)	O
were	O
reduced	O
,	O
and	O
supplement	O
of	O
synthetic	O
cathelicidin	B:C4084937
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
prevented	O
intestinal	O
disease	I:C0021831
.	O

Pancreatic	O
levels	I:C1306845
of	O
cathelicidin	O
-	O
related	O
antimicrobial	O
peptide	I:C4084937
(	O
cathelicidin	O
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
)	O
were	O
reduced	O
,	O
and	O
supplement	O
of	O
synthetic	O
cathelicidin	O
-	I:C4084937
related	I:C4084937
antimicrobial	I:C4084937
peptide	I:C4084937
prevented	O
intestinal	B:C0021831
disease	I:C0021831
.	O

These	O
findings	B:C0243095
reveal	O
a	O
critical	O
role	O
for	O
antimicrobial	O
pancreatic	O
secretion	I:C0232787
in	O
gut	O
innate	O
immunity	O
.	O

These	O
findings	O
reveal	O
a	O
critical	O
role	O
for	O
antimicrobial	B:C1136254
pancreatic	O
secretion	I:C0232787
in	O
gut	O
innate	O
immunity	O
.	O

These	O
findings	O
reveal	O
a	O
critical	O
role	O
for	O
antimicrobial	O
pancreatic	B:C0232787
secretion	I:C0232787
in	O
gut	O
innate	O
immunity	O
.	O

These	O
findings	O
reveal	O
a	O
critical	O
role	O
for	O
antimicrobial	O
pancreatic	O
secretion	I:C0232787
in	O
gut	B:C0699819
innate	O
immunity	O
.	O

